Keywords: fda, warns, astrazeneca, dupont, about, ads, food

FDA warns AstraZeneca and DuPont about ads.

Article | 21 January 2002

Print This

The US Food and Drug Administration has asked AstraZeneca to withdrawan advertisement for its breast cancer drug Nolvadex (tamoxifen citrate) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in